The low expression of ADRB2 in tumor tissues of LUAD patients is correlated with gender, smoking, OS events and DSS events, indicating that ADRB2 is a potential biomarker for prognosis and diagnosis. This evidence concerns the gene ADRB2 and neoplasm.